ArticleHaematologica2023

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.

Nathalie Asherie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.